Literature DB >> 18482621

Integrated testing and management in fetal growth restriction.

Sifa Turan1, Jena Miller, Ahmet A Baschat.   

Abstract

Growth-restricted fetuses are at higher risk for poor perinatal and long-term outcome than those who are appropriately grown. Multiple antenatal testing modalities can help document the sequence of fetal deterioration. The full extent of this compromise is best identified by a combination of fetal biometry, biophysical profile scoring, and arterial and venous Doppler. In the preterm growth-restricted fetus, timing of delivery is critically determined by the balance of fetal versus neonatal risks. In the near-term fetus, accurate diagnosis continues to be a challenge as unrecognized growth restriction contributes to a significant proportion of unexplained stillbirths. In this review, we present an integrated diagnostic and surveillance approach that accounts for these factors.

Mesh:

Year:  2008        PMID: 18482621     DOI: 10.1053/j.semperi.2008.02.008

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  11 in total

1.  Free protein s reference ranges in gravidas without hereditary and acquired thrombophilia.

Authors:  Ahmet Basaran; Özgür Deren; Yahya Buyukasik; Mustafa Basaran
Journal:  Indian J Hematol Blood Transfus       Date:  2014-08-17       Impact factor: 0.900

2.  Delivery of the growth restricted preterm fetus.

Authors:  Neeta L Vora; Nancy Chescheir
Journal:  Lancet       Date:  2015-03-05       Impact factor: 79.321

3.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

4.  Doppler for growth restriction: the association between the cerebroplacental ratio and a reduced interval to delivery.

Authors:  C R Warshak; H Masters; J Regan; E DeFranco
Journal:  J Perinatol       Date:  2014-12-04       Impact factor: 2.521

Review 5.  Defining normal and abnormal fetal growth: promises and challenges.

Authors:  Jun Zhang; Mario Merialdi; Lawrence D Platt; Michael S Kramer
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

Review 6.  Maternal amino acid supplementation for intrauterine growth restriction.

Authors:  Laura D Brown; Alice S Green; Sean W Limesand; Paul J Rozance
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

7.  Dysregulated flow-mediated vasodilatation in the human placenta in fetal growth restriction.

Authors:  Sarah Jones; Helen Bischof; Ingrid Lang; Gernot Desoye; Sue L Greenwood; Edward D Johnstone; Mark Wareing; Colin P Sibley; Paul Brownbill
Journal:  J Physiol       Date:  2015-06-08       Impact factor: 5.182

8.  The role of ultrasound in the diagnosis and management of the growth restricted fetus.

Authors:  Stephen Lee; Susan P Walker
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

Review 9.  Early onset fetal growth restriction.

Authors:  Andrea Dall'Asta; Valentina Brunelli; Federico Prefumo; Tiziana Frusca; Christoph C Lees
Journal:  Matern Health Neonatol Perinatol       Date:  2017-01-18

Review 10.  Antenatal cardiotocography for fetal assessment.

Authors:  Rosalie M Grivell; Zarko Alfirevic; Gillian M L Gyte; Declan Devane
Journal:  Cochrane Database Syst Rev       Date:  2015-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.